-
Align Technology to add three new independent directors, boost 2026 buyback to $400-500M
Board refreshment to add three new independent directors with healthcare, technology, and operational expertise.
-
Align Technology Q2 record revenue $1.06B, Clear Aligner volume up 7.4% YoY; guides Q3 down
Q2'26 total revenue $1,056.2M (+4.3% YoY); Clear Aligner revenue $870.9M (+8.2% YoY) on 691.8k cases (+7.4% YoY).
-
Align Technology EVP and Chief Legal Officer Julie Coletti resigns to join Illumina
Julie Coletti, EVP and Chief Legal & Regulatory Officer, resigned effective August 1, 2026.
-
Align Technology Chairman C. Raymond Larkin to retire; Kevin Conroy appointed as new Chairman.
C. Raymond Larkin to retire as Chairman effective July 1, 2026, and as board member effective Dec. 31, 2026; no disagreement cited.
-
Align Tech shareholders re-elect all 10 directors, approve say-on-pay, auditor, bylaw provision
Proposal 1: All 10 director nominees elected with at least 95% of votes cast (excl. broker non-votes).
-
Align Technology announces $200M open market stock repurchase under $1B program
Plans to repurchase $200M of common stock via open market under $1.0B program authorized April 2025.
-
Align Technology reports Q1 revenue up 6.2% YoY, record Clear Aligner shipments, $200M buyback
Q1 total revenues $1,040.1M, up 6.2% YoY; GAAP diluted EPS $1.57, non-GAAP EPS $2.58.
-
Align Technology amends bylaws to allow 25%+ stockholders to call special meetings
Amended bylaws effective Feb 24, 2026; require 25% continuous ownership for 1 year to request special meeting.
-
Align Q4 record revenue $1.05B, EPS $1.89; FY2026 revenue growth 3-4%
Q4'25 total revenue $1,047.6M (+5.3% YoY); Clear Aligner volume record 676.9k cases (+7.7% YoY).
-
Align Tech Q3 rev $995.7M beats guidance; non-GAAP EPS $2.61; guides Q4 rev $1.025-1.045B
Q3 total revenues $995.7M, up 1.8% YoY, above guidance range of $965M-$985M.
-
Align Technology terminates EVP HR Stuart Hockridge, effective May 2026
Stuart Hockridge, EVP Global Human Resources, terminated effective May 2026.
-
Align Technology announces $200M open market share repurchase
Repurchases under the $1.0B board-approved program from April 2025.
-
Align Q2 revenue $1.01B (-1.6% YoY); guides Q3 down, announces restructuring with $150-170M charges
Q2'25 revenue $1,012.4M (-1.6% YoY); GAAP EPS $1.72, non-GAAP $2.49.
-
Britt Vitalone (McKesson CFO) appointed to Align Technology Board
Appointed effective July 2, 2025; board expanded from 10 to 11 directors.
-
Align Tech shareholders approve incentive plan share increase; special meeting proposals split
Proposal 5 passed: 56.4M for vs 2.5M against, increasing authorized shares under the 2005 Incentive Plan to 34,668,895.
-
Align Technology announces $1B stock buyback; provides long-term financial model
Board authorized $1.0B stock repurchase program over three years, replacing prior $1B program completed May 1, 2025.
-
Align Q1'25 revenue $979.3M, volume up 6.2% YoY; guides Q2 $1.05-1.07B
Q1'25 revenue $979.3M (-1.8% YoY); GAAP EPS $1.27, non-GAAP EPS $2.13.
-
Align Technology to repurchase $225M of common stock to complete $1B buyback program
$225M open market repurchase completes $1.0B program approved Jan 2023.
-
Align Q4 rev $995M (+4% YoY); guides Q1 revenue $965-985M; 3% price hike in March
Q4 GAAP diluted EPS $1.39, non-GAAP $2.44; FY2024 GAAP EPS $5.62, non-GAAP $9.33.
-
Align Technology plans $275M open market stock repurchase under existing $1B program
Repurchase of $275M of common stock via open market under Board-approved $1.0B program from Jan 2023.
-
Align Tech Q3 revenue $977.9M (+1.8% YoY); restructuring, $30M charge in Q4
Q3 GAAP diluted EPS $1.55, non-GAAP $2.35; operating margin 16.6% GAAP, 22.1% non-GAAP.
-
Align Q2 revenue $1.03B up 2.6% YoY; EPS $1.28 GAAP, $2.41 non-GAAP; Q3 revenue guidance $980M-$1,000M
Q2'24 total revenues $1,028.5M (+3.1% QoQ, +2.6% YoY); Clear Aligner volume 642,725 cases (+6.2% QoQ).
-
Align Technology names Emory Wright to lead direct 3D printing; Wright to retire in 2026
Emory Wright moves from EVP Global Operations to EVP Direct Fabrication Manufacturing Platform, focusing on 3D printing and scaling production for next-gen products.
-
Align Technology plans $150M stock repurchase by July 2024
$150M open market repurchase under existing $1.0B program approved Jan 2023.
-
Align Q1 revenue up 5.8% YoY to $997.4M; raises FY24 revenue outlook; invests $75M in Heartland
Q1 GAAP EPS $1.39, non-GAAP $2.14; revenue $997.4M beat prior expectations.
-
Align Q4 rev $956.7M +6.1% YoY; EPS $1.64 ($2.42 non-GAAP); iTero Lumina launch; FY24 guide mid-single digit growth
Q4 total revenue $956.7M (+6.1% YoY); GAAP diluted EPS $1.64; non-GAAP $2.42.
-
Align Technology amends bylaws to align with universal proxy rules and update governance provisions
Prohibit stockholder from nominating more directors than seats up for election.
-
Align appoints Kevin Conroy (Exact Sciences CEO) and Mojdeh Poul to board, expands to 10 directors
Kevin Conroy, CEO/Chairman of Exact Sciences, and Mojdeh Poul, former 3M Health Care EVP, joined Align's board effective December 5, 2023.
-
Align Technology announces $100M open market stock repurchase; CEO to buy $1M personally
$100M open market repurchase under existing $1.0B buyback program approved Jan 2023.
-
Align Technology enters $250M accelerated share repurchase; CEO plans $1M personal stock purchase
$250M ASR with Citibank; initial delivery ~1M shares; final count based on VWAP less discount.
-
Align Q3 revenue $960.2M (+7.8% YoY); Q4 guidance $920M-$940M
Q3 GAAP EPS $1.58, non-GAAP $2.14; operating margin 17.3% GAAP, 21.8% non-GAAP.
-
Align Technology to acquire Cubicure GmbH for ~€79M to bolster direct 3D printing capabilities
Purchase price ~€79M (~$85M), expected to close Q4 2023 or early 2024, no financing conditions.
-
California court confirms $63M arbitration award for Align against SmileDirectClub; SDC motion to vacate denied
Superior Court of Santa Clara County confirmed $63M final arbitration award in Align's favor and denied SDC's petition to vacate.
-
Align Technology Q2 beats: rev $1.002B (+3.4% YoY), EPS $2.22, teen cases +10%
Q2 total revenues $1.002B, up 6.3% sequentially and 3.4% YoY; GAAP EPS $1.46, non-GAAP EPS $2.22.
-
ALGN stockholders approve incentive plan amendment and exculpation; say-on-pay passes with 84% support
Elected 8 directors; Joseph Lacob received 54.9M for, 9.99M against (~15% against).
-
Align Technology Q1 revenue $943M beats expectations; guides Q2 revenue $980M-$1,000M
Q1 revenue $943.1M, up 4.6% sequentially; GAAP EPS $1.14, non-GAAP $1.82.
-
Align Technology adopts proxy access bylaw allowing 3% holders to nominate directors
Board approved amended bylaws on Feb 27, 2023 adding proxy access for director nominations.
-
Align Technology enters $250M accelerated stock repurchase; CEO & CFO to buy shares
Entered $250M ASR with Citibank under existing $1B repurchase program from May 2021.
-
Align Q4 revenue $901.5M (-12.6% YoY); board authorizes new $1B buyback
Q4 total revenue $901.5M, down 12.6% YoY; GAAP diluted EPS $0.54, non-GAAP $1.73.
-
Align Technology amends credit facility: extends maturity to Dec 2027, relaxes covenants, switches to SOFR
Extended maturity of $300M unsecured revolver from July 2023 to December 2027.
-
Align Technology enters $200M accelerated stock repurchase; CEO plans $2M personal purchase
Align entered $200M ASR with Goldman Sachs to repurchase shares under $1B buyback program; initial delivery ~849k shares.
-
Align Technology enters $200M accelerated share repurchase; CEO to buy $2M personally
Entered $200M accelerated share repurchase (ASR) with Goldman Sachs; initial delivery ~849,000 shares.
-
Align Technology Q3 revenue $890.3M, down 12.4% YoY; EPS $0.93 vs $2.28
Q3 total revenues $890.3M, down 12.4% YoY; Clear Aligner revenue $732.8M (down 12.5% YoY), volume 577.2K cases (down 11.9% YoY).
-
Align Technology Q2 2022: Rev $969.6M, GAAP EPS $1.44, non-GAAP $2.00, Clear Aligner volume down 10% YoY
Q2 total rev $969.6M, down 0.4% sequentially and 4.1% YoY; foreign exchange hurt rev by ~$15.3M sequentially.
-
Align Tech shareholders elect all 10 director nominees, ratify auditor, approve say-on-pay at 2022 annual meeting
All 10 board nominees elected; votes ranged from 54.5M (Lacob) to 66.4M (Dallas) with 3.4M non-votes.
-
Align Technology launches $200M accelerated stock repurchase; CEO plans $2M personal purchase
$200M ASR with Citibank; initial delivery of approx. 552,000 shares.
-
Align Technology enters $200M accelerated stock buyback; CEO to buy $2M shares
ASR contract with Citibank to repurchase $200M of common stock under existing $1B program.
-
Align Tech Q1 rev $973.2M (+8.8% YoY) but EPS $1.70 down 32%; cites headwinds
Q1 total revenues $973.2M, up 8.8% YoY, down 5.6% sequentially; Clear Aligner rev $809.7M (+7.5% YoY).
-
Align Technology settles patent and antitrust litigation with 3Shape A/S
Settlement resolves litigation that began in November 2017 involving patent and antitrust claims.
-
Align Technology reports record Q4 revenue $1.03B, FY2021 revenue up 59.9% to $4.0B
Q4 GAAP EPS $2.40, non-GAAP $2.83; FY21 GAAP EPS $9.69 (down 56.5% YoY on prior year one-time gain), non-GAAP EPS $11.22 up 114.8%.